Replimune Group Inc. (REPL) News Headlines

▮ More

Date

Headline

1/5/2021 8:25:30 AM Replimune Doses First Patient In Phase 1 Clinical Trial Of RP3

11/20/2020 1:46:37 AM AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B

11/8/2020 9:52:03 AM Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing

10/22/2020 1:10:48 AM Replimune Prices Public Offering Of 4.69 Mln Shares At $40/Shr

10/15/2020 2:06:24 AM FDA Approves 1st Ebola Drug, CYCN Drops Sickle Cell Disease Drug, VRTX Plunges In After-hours Trade

7/22/2020 7:22:19 AM Replimune Appoints Andrea Pirzkall As Chief Medical Officer, Effective August 31, 2020

6/4/2020 11:32:57 PM CYCN Awaits Sickle Cell Disease Data, TTPH Finalizes Its Suitor, ADMS Faces FDA In Feb

6/3/2020 7:21:39 AM Replimune Q4 Net Loss $15.8 Mln Vs Net Loss $6.7 Mln Last Year

11/14/2019 6:36:10 AM Replimune Prices Public Offering Of 3.68 Mln Shares At $13.61 Per Share

9/19/2019 9:39:05 PM 6 Top Gainers In Healthcare Sector (AIM, EDSA, ARAV…)

4/24/2019 9:36:27 PM Wedbush Starts Replimune Group Inc. (REPL) At Outperform With $24 Price Target

2/11/2019 8:51:00 PM 6 Top Gainers In Healthcare Sector (NMRD, PTI, MGTA...)

11/14/2018 8:19:19 AM Replimune Group Q4 Net Loss Widens To $6.46 Mln From $4.66 Mln Last Year

8/30/2018 11:27:38 PM CRON Goes Up In Smoke On Citron Report, Hot AFMD Is Cooling Now, REPL On Watch

8/30/2018 8:10:57 AM Replimune Q1 Net Loss $10.0 Mln

8/28/2018 9:11:53 PM AFMD Notches Triple-digit Gains, AXSM Strides Ahead, GERON Abuzz

7/16/2018 2:52:55 AM This Week's Biotech IPOs

Older Articles